ASXNotification regarding unquoted securities - MYX
other announcement
MAYNE PHARMA LTD ORDINARY (MYX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Google NewsMayne Pharma (ASX:MYX): Pharma Stock Gains as Healthcare Investors Watch Recovery Catalysts - Kalkine
Mayne Pharma (ASX:MYX): Pharma Stock Gains as Healthcare Investors Watch Recovery Catalysts Kalkine
Mayne Pharma Group (ASX:MYX) Share Price Rises 3.89% as Healthcare Stocks Gain Momentum - Kalkine
Mayne Pharma Group (ASX:MYX) Share Price Rises 3.89% as Healthcare Stocks Gain Momentum Kalkine
KalkineAdveritas (ASX:AV1), Mayne Pharma (ASX:MYX): Penny Stocks to Watch
Highlights Adveritas, Mayne Pharma and Wagners Holding continue attracting attention across the small-cap segment. Strong balance sheets and improving operational performance remain key themes among emerging companies. Investors continue assessing financial strength alongside long-term growth prospects within smaller ASX-listed businesses. Smaller listed companies continue drawing market attention as investors search for businesses with improving financial str...
Mayne Pharma appoints new Non-Executive Director
other announcement
What’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares? - Kalkine
What’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares? Kalkine
Mayne Pharma receives $14.4m for legal costs from Cosette
other announcement
MYX Jefferies Global Healthcare Conference Presentation
other announcement
New DistributeRx partnership with Resilia Pharmaceuticals
other announcement
Mayne Pharma to present at Jefferies Healthcare Conference
other announcement
Mayne Pharma wins $13.27m costs award against Cosette from collapsed $672m takeover battle
Adelaide-based pharmaceutical manufacturer Mayne Pharma (ASX: MYX) has been awarded $13.27 million in legal costs by the Supreme Court of NSW against Cosette Pharmaceuticals, the latest salvo in a protracted dispute stemming from a $672 million takeover deal that collapsed after the Australian Treasurer blocked it on national interest groun...
Court awards MYX $13.27m for legal costs from Cosette
other announcement
Mayne Pharma announces expansion of Adelaide Apothecary
other announcement
Further details re equity instruments to be issued to CEO
other announcement
MYX expects no material impact from US s232 tariffs
other announcement
Non-Executive Director retirement and recruitment
other announcement
Mayne Pharma ASX SMIDcaps conference presentation
other announcement
Mayne Pharma to present at ASX SMIDcaps Conference
other announcement
Notification of date for release of 1H26 results
other announcement
MYX to claim against Cosette, Avista & Mr David Burgstahler
other announcement
Notification regarding unquoted securities - MYX
other announcement
Notification regarding unquoted securities - MYX
other announcement